161 related articles for article (PubMed ID: 8869815)
1. Sequestered endoplasmic reticulum space for sequential metabolism of salicylamide. Coupling of hydroxylation and glucuronidation.
Tirona RG; Pang KS
Drug Metab Dispos; 1996 Aug; 24(8):821-33. PubMed ID: 8869815
[TBL] [Abstract][Full Text] [Related]
2. Sequential metabolism of salicylamide exclusively to gentisamide 5-glucuronide and not gentisamide sulfate conjugates in single-pass in situ perfused rat liver.
Xu X; Tang BK; Pang KS
J Pharmacol Exp Ther; 1990 Jun; 253(3):965-73. PubMed ID: 2359032
[TBL] [Abstract][Full Text] [Related]
3. Hepatic modeling of metabolite kinetics in sequential and parallel pathways: salicylamide and gentisamide metabolism in perfused rat liver.
Xu X; Pang KS
J Pharmacokinet Biopharm; 1989 Dec; 17(6):645-71. PubMed ID: 2635738
[TBL] [Abstract][Full Text] [Related]
4. Competing pathways in drug metabolism. I. Effect of input concentration on the conjugation of gentisamide in the once-through in situ perfused rat liver preparation.
Morris ME; Yuen V; Tang BK; Pang KS
J Pharmacol Exp Ther; 1988 May; 245(2):614-24. PubMed ID: 3367309
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: a multiple indicator dilution study.
Pang KS; Barker F; Schwab AJ; Goresky CA
J Pharmacol Exp Ther; 1994 Jul; 270(1):285-95. PubMed ID: 8035326
[TBL] [Abstract][Full Text] [Related]
6. First-pass metabolism of salicylamide. Studies in the once-through vascularly perfused rat intestine-liver preparation.
Xu X; Hirayama H; Pang KS
Drug Metab Dispos; 1989; 17(5):556-63. PubMed ID: 2573500
[TBL] [Abstract][Full Text] [Related]
7. First-pass metabolism of gentisamide: influence of intestinal metabolism on hepatic formation of conjugates. Studies in the once-through vascularly perfused rat intestine-liver preparation.
Hirayama H; Pang KS
Drug Metab Dispos; 1990; 18(5):580-7. PubMed ID: 1981705
[TBL] [Abstract][Full Text] [Related]
8. Normal and retrograde perfusion to probe the zonal distribution of sulfation and glucuronidation activities of harmol in the perfused rat liver preparation.
Pang KS; Koster H; Halsema IC; Scholtens E; Mulder GJ; Stillwell RN
J Pharmacol Exp Ther; 1983 Mar; 224(3):647-53. PubMed ID: 6827487
[TBL] [Abstract][Full Text] [Related]
9. Differences in excretion of hippurate, as a metabolite of benzoate and as an administered species, in the single-pass isolated perfused rat kidney explained.
Geng W; Pang KS
J Pharmacol Exp Ther; 1999 Feb; 288(2):597-606. PubMed ID: 9918564
[TBL] [Abstract][Full Text] [Related]
10. Futile cycling between 4-methylumbelliferone and its conjugates in perfused rat liver.
Ratna S; Chiba M; Bandyopadhyay L; Pang KS
Hepatology; 1993 May; 17(5):838-53. PubMed ID: 8491453
[TBL] [Abstract][Full Text] [Related]
11. Futile cycling of estrone sulfate and estrone in the recirculating perfused rat liver preparation.
Tan E; Lu T; Pang KS
J Pharmacol Exp Ther; 2001 Apr; 297(1):423-36. PubMed ID: 11259571
[TBL] [Abstract][Full Text] [Related]
12. Renal handling of enalapril and enalaprilat: studies in the isolated red blood cell-perfused rat kidney.
de Lannoy IA; Nespeca R; Pang KS
J Pharmacol Exp Ther; 1989 Dec; 251(3):1211-22. PubMed ID: 2557416
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent bioavailability and metabolism of salicylamide in dogs.
Waschek JA; Rubin GM; Tozer TN; Fielding RM; Couet WR; Effeney DJ; Pond SM
J Pharmacol Exp Ther; 1984 Jul; 230(1):89-93. PubMed ID: 6747835
[TBL] [Abstract][Full Text] [Related]
14. Alteration of transit time and direction of flow to probe the heterogeneous distribution of conjugating activities for harmol in the perfused rat liver preparation.
Dawson JR; Weitering JG; Mulder GJ; Stillwell RN; Pang KS
J Pharmacol Exp Ther; 1985 Sep; 234(3):691-7. PubMed ID: 4032287
[TBL] [Abstract][Full Text] [Related]
15. Salicylamide sulfate cell entry in perfused rat liver: a multiple-indicator dilution study.
Xu X; Schwab AJ; Barker F; Goresky CA; Pang KS
Hepatology; 1994 Jan; 19(1):229-44. PubMed ID: 8276359
[TBL] [Abstract][Full Text] [Related]
16. Moment analysis of metabolic heterogeneity: conjugation of benzoate with glycine in rat liver studied by multiple indicator dilution technique.
Schwab AJ; Tao L; Kang M; Meng L; Pang KS
J Pharmacol Exp Ther; 2003 Apr; 305(1):279-89. PubMed ID: 12649380
[TBL] [Abstract][Full Text] [Related]
17. Estimations of intestinal and liver first-pass metabolism in vivo. Studies on gentisamide conjugation in the rat.
Hirayama H; Morgado J; Gasinska I; Pang KS
Drug Metab Dispos; 1990; 18(5):588-94. PubMed ID: 1981706
[TBL] [Abstract][Full Text] [Related]
18. Competing pathways in drug metabolism. II. An identical, anterior enzymic distribution for 2- and 5-sulfoconjugation and a posterior localization for 5-glucuronidation of gentisamide in the rat liver.
Morris ME; Yuen V; Pang KS
J Pharmacokinet Biopharm; 1988 Dec; 16(6):633-56. PubMed ID: 3251033
[TBL] [Abstract][Full Text] [Related]
19. Carrier-mediated entry of 4-methylumbelliferyl sulfate: characterization by the multiple-indicator dilution technique in perfused rat liver.
Chiba M; Schwab AJ; Goresky CA; Pang KS
Hepatology; 1998 Jan; 27(1):134-46. PubMed ID: 9425929
[TBL] [Abstract][Full Text] [Related]
20. Nonlinear protein binding and enzyme heterogeneity: effects on hepatic drug removal.
Xu X; Selick P; Pang KS
J Pharmacokinet Biopharm; 1993 Feb; 21(1):43-74. PubMed ID: 8410683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
